Zelos Therapeutics Inc. is moving its headquarters from Waltham to Philadelphia after the company named a new CEO who is based in the City of Brotherly Love. The drug development company keeps relatively small business development and corporate offices in Waltham and research facilities in Ottawa, Ontario. At its peak the office included the CEO and a few adminstrative staff members.
